MRI Screening Versus SYMptom-directed Surveillance for Brain Metastases Among Patients With Triple Negative or HER2+ MBC
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm|Brain Metastases|Triple Negative Breast Cancer|HER2-positive Breast Cancer
Interventions: DIAGNOSTIC_TEST: MRI screening
Sponsor: Sunnybrook Health Sciences Centre
Collaborators: Harvard University